Kevin P Starr - Net Worth and Insider Trading
Kevin P Starr Net Worth
The estimated net worth of Kevin P Starr is at least $1.4 Billion dollars as of 2024-06-07. Kevin P Starr is the 10% Owner of Global Blood Therapeutics Inc and owns about 8,843,448 shares of Global Blood Therapeutics Inc (GBT) stock worth over $606 Million. Kevin P Starr is the 10% Owner of Blueprint Medicines Corp and owns about 5,453,753 shares of Blueprint Medicines Corp (BPMC) stock worth over $569 Million. Kevin P Starr is also the Director, 10% Owner of MyoKardia Inc and owns about 826,001 shares of MyoKardia Inc (MYOK) stock worth over $186 Million. Besides these, Kevin P Starr also holds Agios Pharmaceuticals Inc (AGIO) , Editas Medicine Inc (EDIT) , CytomX Therapeutics Inc (CTMX) , Sage Therapeutics Inc (SAGE) , Zafgen Inc (ZFGN) , Alnylam Pharmaceuticals Inc (ALNY) . Details can be seen in Kevin P Starr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kevin P Starr has not made any transactions after 2018-04-18 and currently still holds the listed stock(s).
Transaction Summary of Kevin P Starr
Kevin P Starr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin P Starr owns 24 companies in total, including Revolution Medicines Inc (RVMD) , Nurix Therapeutics Inc (NRIX) , and Relay Therapeutics Inc (RLAY) among others .
Click here to see the complete history of Kevin P Starr’s form 4 insider trades.
Insider Ownership Summary of Kevin P Starr
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RVMD | Revolution Medicines Inc | 2020-02-12 | 10 percent owner |
NRIX | Nurix Therapeutics Inc | 2020-07-23 | 10 percent owner |
RLAY | Relay Therapeutics Inc | 2020-07-15 | 10 percent owner |
2018-04-18 | director & 10 percent owner | ||
2020-06-02 | 10 percent owner | ||
2019-07-17 | 10 percent owner | ||
2016-12-19 | 10 percent owner | ||
2017-10-04 | 10 percent owner | ||
2018-08-22 | 10 percent owner | ||
2018-06-29 | 10 percent owner | ||
2018-03-07 | director & 10 percent owner | ||
2017-11-01 | 10 percent owner | ||
2017-04-12 | 10 percent owner | ||
2016-12-16 | 10 percent owner | ||
2015-11-12 | director | ||
2016-12-19 | 10 percent owner | ||
2017-01-26 | 10 percent owner | ||
2016-09-06 | 10 percent owner | ||
2015-07-13 | director & 10 percent owner | ||
2015-05-14 | 10 percent owner | ||
2014-05-30 | director | ||
2014-02-05 | 10 percent owner | ||
2021-02-11 | 10 percent owner | ||
2014-02-05 | 10 percent owner |
Kevin P Starr Latest Holdings Summary
Kevin P Starr currently owns a total of 9 stocks. Among these stocks, Kevin P Starr owns 8,843,448 shares of Global Blood Therapeutics Inc (GBT) as of December 16, 2016, with a value of $606 Million and a weighting of 42.64%. Kevin P Starr owns 5,453,753 shares of Blueprint Medicines Corp (BPMC) as of December 19, 2016, with a value of $569 Million and a weighting of 40.09%. Kevin P Starr also owns 826,001 shares of MyoKardia Inc (MYOK) as of January 3, 2018, with a value of $186 Million and a weighting of 13.08%. The other 6 stocks Agios Pharmaceuticals Inc (AGIO) , Editas Medicine Inc (EDIT) , CytomX Therapeutics Inc (CTMX) , Sage Therapeutics Inc (SAGE) , Zafgen Inc (ZFGN) , Alnylam Pharmaceuticals Inc (ALNY) have a combined weighting of 4.2% among all his current holdings.
Latest Holdings of Kevin P Starr
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GBT | Global Blood Therapeutics Inc | 2016-12-16 | 8,843,448 | 68.49 | 605,687,754 |
BPMC | Blueprint Medicines Corp | 2016-12-19 | 5,453,753 | 104.42 | 569,480,888 |
MYOK | MyoKardia Inc | 2018-01-03 | 826,001 | 224.91 | 185,775,885 |
AGIO | Agios Pharmaceuticals Inc | 2013-07-23 | 545,454 | 47.80 | 26,072,701 |
EDIT | Editas Medicine Inc | 2016-09-06 | 3,906,176 | 5.43 | 21,210,536 |
CTMX | CytomX Therapeutics Inc | 2017-04-12 | 5,201,767 | 1.67 | 8,686,951 |
SAGE | Sage Therapeutics Inc | 2018-04-18 | 340,179 | 10.77 | 3,663,728 |
ZFGN | Zafgen Inc | 2015-09-24 | 30,860 | 0.99 | 30,551 |
ALNY | Alnylam Pharmaceuticals Inc | 2015-11-12 | 0 | 149.30 | 0 |
Holding Weightings of Kevin P Starr
Kevin P Starr Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin P Starr has made a total of 0 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years. The most-recent trade in Global Blood Therapeutics Inc is the sale of 108,955 shares on December 16, 2016, which brought Kevin P Starr around $2 Million.
According to the SEC Form 4 filings, Kevin P Starr has made a total of 0 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years. The most-recent trade in Blueprint Medicines Corp is the sale of 106,489 shares on December 19, 2016, which brought Kevin P Starr around $3 Million.
According to the SEC Form 4 filings, Kevin P Starr has made a total of 0 transactions in MyoKardia Inc (MYOK) over the past 5 years. The most-recent trade in MyoKardia Inc is the sale of 816,326 shares on January 3, 2018, which brought Kevin P Starr around $34 Million.
More details on Kevin P Starr's insider transactions can be found in the Insider Trading History of Kevin P Starr table.Insider Trading History of Kevin P Starr
- 1
Kevin P Starr Trading Performance
Kevin P Starr Ownership Network
Ownership Network List of Kevin P Starr
Ownership Network Relation of Kevin P Starr
Kevin P Starr Owned Company Details
What does Revolution Medicines Inc do?
Who are the key executives at Revolution Medicines Inc?
Kevin P Starr is the 10 percent owner of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include director & See Remarks Mark A Goldsmith , General Counsel Jeff Cislini , and Chief Financial Officer Jack Anders .
Revolution Medicines Inc (RVMD) Insider Trades Summary
Over the past 18 months, Kevin P Starr made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 91,644 shares made by Margaret A Horn , a net sale of 97,493 shares made by Stephen Michael Kelsey , and a net sale of 14,434 shares made by Jeff Cislini .
In summary, during the past 3 months, insiders sold 77,164 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 77,164 shares. During the past 18 months, 346,190 shares of Revolution Medicines Inc (RVMD) were sold and 650,000 shares were bought by its insiders, resulting in a net purchase of 303,810 shares.
Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revolution Medicines Inc Insider Transactions
Kevin P Starr Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin P Starr. You might contact Kevin P Starr via mailing address: 29 Newbury Street, 3rd Floor, Boston Ma 02116.